Search

Displaying 81 - 90 of 1167

Say Goodbye to High Blood Potassium With These Dietitian-Approved Tips

Whether you are a dialysis patient or just watching your diet, you know that you are what you eat. And while fruits and veggies are healthy choices, high-potassium foods are important to monitor when living with kidney disease...

 

               National Kidney Foundation and Medtronic survey found dialysis patients’ top concerns potentially better addressed by minimally invasive AV fistula creation procedures

(July 21, 2023, New York, NY) - A survey recently conducted by Medtronic and the National Kidney Foundation (NKF) found that patients undergoing hemodialysis lack awareness about minimally...

June 12, 2023, New York, NY —The National Kidney Foundation (NKF) is proud to announce its latest investment through the NKF's Innovation Fund in Klinrisk, an artificial intelligence-based medical device company. Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction and decision support.

...

(June 1, 2023, New York, NY) — The National Kidney Foundation (NKF) is thrilled to announce the appointment of Dr. John Wigneswaran (Dr. Wig), Walmart’s Chief Medical Officer, to NKF’s National Board of Directors. In his role at Walmart, Dr. Wig leads safety, quality, and training, the Walmart Healthcare Research Institute...

When Joe was seven, his mother frequently visited the hospital, culminating in a four-month medically induced coma. As a child, he wasn't aware of what his mother was battling, only that she wasn't home and missed Thanksgiving or Christmas. It wasn't until he turned thirteen that he learned the truth.

Growing up around kidney disease

When Joe was in middle school, his grandparents sat him down to explain that his mother had...

(April 12, 2023, New York, NY) — The National Kidney Foundation (NKF) will feature a late-breaking plenary session by Travere Therapeutics on the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating FILSPARI™ (sparsentan) in adults with IgA nephropathy (IgAN). “Rapid and Sustained Proteinuria Reduction with Sparsentan in Immunoglobulin A Nephropathy (IgAN): PROTECT Study Interim Results...

(April 14, 2022, AUSTIN, TX) —The main results of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial, a National Heart, Lung, and Blood Institute (NHLBI) sponsored trial were presented. Although the results of the trial are not final, they offer valuable information for patients using the generic drug Spironolactone. This drug therapy activates white cells and...

National Kidney Foundation Launches New Public Education Series on Hyperkalemia

~Animated Video Series and Patient Videos Illustrate What You Need to Know about High Potassium and CKD~

(Feb. 28, 2023, New York, NY) – The National Kidney Foundation (NKF) has launched a new animated video series to educate people with...

(April 11, 2023, New York, NY) — University of Illinois at Chicago (UIC) nephrologist Ana Ricardo, MD, will receive the National Kidney Foundation (NKF) Medical Advisory Board Distinguished Service Award, which recognizes individuals for their educational activities and community service in promoting the mission of NKF on a local level. The award will be presented at the 2023 Spring Clinical Meetings in Austin, TX, April 11-15.

Dr....

(April 5, 2023, New York, NY) — Alfred K. Cheung, MD, a clinical nephrologist and researcher, will receive the National Kidney Foundation’s (NKF) David M. Hume Memorial Award for his high ideals of scholarship and humanism in an outstanding manner in the field of academic nephrology. The award will be presented at the NKF Spring Clinical Meetings in Austin, TX this month.

          ...